Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2011 pubmed 43 citations

Association of vitamin D and antimicrobial peptide production during late-phase allergic responses in the lung.

Liu. M C MC; Xiao. H-Q HQ; Brown. A J AJ; Ritter. C S CS; Schroeder. J J

Key Findings

  • Allergen exposure increased airway levels of 1,25‑(OH)2D and 25‑(OH)D in bronchoalveolar lavage fluid
  • LL‑37 concentrations rose sharply after allergen challenge and correlated strongly with vitamin D metabolites
  • The rise in vitamin D and LL‑37 was linked to inflammation markers and albumin, implying plasma leakage as the source

Practical Outcomes

  • Vitamin D may enhance lung innate immunity by raising LL‑37 during allergic or inflammatory events. For biohackers, maintaining adequate vitamin D status could support respiratory antimicrobial defenses, but the data are limited to allergic responses and do not define a specific supplement dose or protocol.

Summary

The study found that after an allergic reaction in the lungs, levels of active vitamin D and the antimicrobial peptide LL‑37 both rise together, suggesting vitamin D helps boost this natural defense protein during inflammation.

Abstract

Vitamin D may play important roles in regulating immune responses and in defence against infectious diseases by effects on both innate and adaptive immune responses. Little is known regarding activation of vitamin D within airway tissues and its relationship to inflammation and antimicrobial responses. The objective of this study was to investigate the activation of vitamin D within the airways and to define relationships between vitamin D metabolites and measures of inflammatory and antimicrobial responses assessed by bronchoalveolar lavage (BAL) during late-phase responses following allergen challenge of allergic subjects. Segmental allergen challenge was performed with saline and allergen in 16 adult allergic subjects. BAL was performed in both saline and allergen-challenged sites 20-24 h. after challenge. Following extraction from BAL fluids, levels of 25-hydroxy-vitamin D (25(OH)D) and 1,25-dihydroxy-vitamin D (1,25(OH)(2)D) were assayed by specific radioimmunoassays. The cleavage product of cathelicidin, LL-37, was assayed by ELISA. Cellular constituents and albumin were measured. Levels of vitamin D metabolites were increased in concentrated BAL fluids after allergen compared to saline challenge. Levels of 1,25(OH)(2)D increased from largely undetectable to 2.5 pm (median; range: 1-29.5; P = 0.005) while 25(OH)D increased from 3.2 (0.8-6.2) to 6.2 (1.5-184.9) nm (P = 0.0006). Levels of LL-37 increased from 2.1 (1.4-4.1) to 14.5 (2.2-106.7) ng/mL BAL (P = 0.0005). Levels of LL-37, 1,25(OH)(2)D, and 25(OH)D following allergen challenge were correlated with each other (P < 0.0001), cellular changes, and levels of albumin (P < 0.001). Levels of vitamin D metabolites, particularly 1,25(OH)(2)D, were low within the airways and increased after allergen challenge. The increases correlated with the magnitude of inflammation and increases in cathelicidin. Normalization to albumin suggested plasma exudation as a mechanism for the increases. The findings support a role for vitamin D in allergic and innate immune responses in the lung.

Study Information

Provider

pubmed

Year

2011

Date

2011-10-10T00:00:00.000Z

DOI

10.1111/j.1365-2222.2011.03879.x

Citations

43

References

37